Ieva Palubeckaitė

4PUBLICATIONS
15CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Solid tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 02, 2023
Does PARP Inhibition Sensitize Chondrosarcoma Cell Lines to Chemotherapy or Radiotherapy? Results From a Three-dimensional Spheroid Cell Model.

Ieva Palubeckaitė, Sanne Venneker, Brendy E W M van den Akker

|Dec 18, 2021
A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target.

Natasja Franceschini, Raffaele Gaeta, Paul Krimpenfort

|Jul 02, 2021
Targeting the NAD Salvage Synthesis Pathway as a Novel Therapeutic Strategy for Osteosarcomas with Low NAPRT Expression.

Natasja Franceschini, Jan Oosting, Maud Tamsma

Pageof 1